This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 11/24/2020
Location: Virtual
Subject: COVID-19 Vaccine Emergency Use Authorization Process
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Vaccinate Your Family staff and patient advocacy stakeholders

Event Date: 11/24/2020
Location: Virtual
Subject: COVID-19 Vaccine Emergency Use Authorization Process
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Association of State and Territorial Health Officials

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 11/23/2020
Location: Virtual
Subject: Probiotics for Prevention of Respiratory Infections
FDA Participant/Group: JOSEPH FRANKLIN;
Non FDA Participant/Group: Jillian Hurst, Matthew Kelly (Duke University Medical Center);

Event Date: 11/24/2020
Location: Virtual
Subject: National Academy of Medicine Future of Digitally Enabled Health Paper
FDA Participant/Group: N/A
Non FDA Participant/Group: Peter Lee (Microsoft); Ariana Bailey, Elaine Fontaine, Laura Adams, Mahnoor Ahmed (National Academy of Medicine); David Shaywitz (Harvard);

Event Date: 11/24/2020
Location: Virtual
Subject: COVID-19 Evidence Accelerator Therapeutics Parallel Analysis Working Group Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academics, industry, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 11/23/2020
Location: Virtual
Subject: Food Safety Update for the American-Hellenic Chamber of Commerce's 5th Export USA Forum
FDA Participant/Group: N/A
Non FDA Participant/Group: Members from the Greece exporting community

Event Date: 11/24/2020
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Michael Dykes (International Dairy Foods Association);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 11/24/2020
Location: Virtual
Subject: Chatham House Virtual Roundtable; Panel: COVID-19 Vaccine Development, Transparency, Safety and Public Communication
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other registered guests

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event